Dr. Beutler's research has focused on how the gut and the brain communicate with each other to maintain body weight, and how this goes awry in diseases such as obesity. This interview focuses on new research, including dual incretin agonist tirzepatide as the first pharmacological agent that rivals the efficacy of bariatric surgery for obesity management.
